Recent News
June 23, 2025 — The Defense Commissary Agency publicized a voluntary nationwide recall by Medtech Products Inc., a Prestige Consumer Healthcare company, for five lots of Little Remedies® Honey Cough Syrup due to Bacillus cereus contamination and shelf-stability loss; affected lots distributed from 12/14/2022 through 06/04/2025. June 25, 2025 — Local reports in Antigua confirmed the recalled lots appeared in that market and reiterated UPCs, lot numbers, and expiration dates subject to the recall.
Technical Analysis
ADX / DI+/DI-: ADX at 43.34 signals very strong directional strength. DI+ shows a dip-and-reversal pattern and DI- shows a peak-and-reversal pattern; both patterns indicate a directional shift that supports a bullish short-term tilt despite DI- currently exceeding DI+ in absolute value.
MACD: MACD sits at -1.67 with the signal at -1.78; MACD recently crossed above its signal line while registering a dip-and-reversal pattern, indicating bullish momentum building from negative territory.
MRO (Momentum/Regression Oscillator): MRO reads 3.49 (positive), implying price sits above the target and carries a tendency to mean-revert; the MRO shows a dip-and-reversal pattern that aligns with the MACD signal of re-accelerating upward momentum in the very near term.
RSI: RSI at 34.35 with a dip-and-reversal pattern places the stock near oversold levels while showing early signs of recovery, supporting a potential short-term bounce if momentum indicators hold.
Price vs Moving Averages & Ichimoku: Last close $63.10 trades below the 20-day average $64.82, 50-day average $69.22, and 200-day average $79.17, and below the Ichimoku cloud (Senkou A $71.28, Senkou B $75.31). Price recently traded just below the 1x lower Bollinger band ($63.23), placing the market price at the low end of recent volatility ranges.
Fundamental Analysis
Profitability & Margins: EBIT equals $71,980,000 and EBIT margin stands at 28.85%, improving QoQ by 0.96% and YoY by 7.70%. That EBIT margin sits above the industry peer mean of -3.27% and above the industry peer high of 24.50%.
Income Statement & Cash Flow: Total revenue $249,530,000 with gross profit $140,331,000 and gross margin 56.24% (YoY +2.89%). Operating margin 28.76% (QoQ +0.65%, YoY +7.36%). Operating cash flow $79,013,000, free cash flow $78,175,000 and free cash flow yield 2.16%, above the industry peer mean free cash flow yield of 1.35%.
Capital Structure & Liquidity: Cash and short-term investments $139.50M, current ratio 4.38 (above the industry peer mean current ratio of 1.20), quick ratio 2.99, and cash ratio 1.27. Net debt $853.25M and total debt $1,042.72M produce a debt-to-equity ratio of 0.56, below the industry peer mean of 1.35, while debt-to-EBITDA sits at 13.09, indicating elevated leverage relative to earnings-generation.
Growth & Returns: Reported revenue growth shows a YoY increase of 3.46% while overall revenue growth metric reads -15.85%; earnings per share came in at $0.95 versus an estimate of $0.99 (EPS surprise -4.04%). Return on equity equals 2.56% and return on assets 1.39%, both modest but positive and above industry peer means that sit negative in some measures.
Valuation Context: Price-to-earnings stands at 83.61 with forward PE ~70.32, price-to-sales 14.52, and price-to-book 1.95 (below the industry peer mean P/B of 7.63). Enterprise multiple 56.83 and enterprise value $4,526,219,547. WMDST values the stock as under-valued.
MOST-RECENT QUARTERLY REPORT
| REPORT PERIOD ENDING: | 2025-06-30 |
| REPORT DATE: | 2025-08-07 |
| NEXT REPORT DATE: | 2025-11-05 |
| CASH FLOW | Begin Period Cash Flow | $ 97.9 M |
| Operating Cash Flow | $ 79.0 M | |
| Capital Expenditures | $ -838.00 K | |
| Change In Working Capital | $ 12.0 M | |
| Dividends Paid | — | |
| Cash Flow Delta | $ 41.6 M | |
| End Period Cash Flow | $ 139.5 M | |
| INCOME STATEMENT | REVENUE | |
| Total Revenue | $ 249.5 M | |
| Forward Revenue | $ 77.1 M | |
| COSTS | ||
| Cost Of Revenue | $ 109.2 M | |
| Depreciation | $ 7.7 M | |
| Depreciation and Amortization | $ 7.7 M | |
| Research and Development | — | |
| Total Operating Expenses | $ 177.8 M | |
| PROFITABILITY | ||
| Gross Profit | $ 140.3 M | |
| EBITDA | $ 79.6 M | |
| EBIT | $ 72.0 M | |
| Operating Income | $ 71.8 M | |
| Interest Income | — | |
| Interest Expense | $ 10.2 M | |
| Net Interest Income | $ -10.20 M | |
| Income Before Tax | $ 61.8 M | |
| Tax Provision | $ 14.3 M | |
| Tax Rate | 23.2 % | |
| Net Income | $ 47.5 M | |
| Net Income From Continuing Operations | $ 47.5 M | |
| EARNINGS | ||
| EPS Estimate | $ 0.99 | |
| EPS Actual | $ 0.95 | |
| EPS Difference | $ -0.04 | |
| EPS Surprise | -4.04 % | |
| Forward EPS | $ 1.19 | |
| BALANCE SHEET | ASSETS | |
| Total Assets | $ 3.4 B | |
| Intangible Assets | $ 2.8 B | |
| Net Tangible Assets | $ -967.66 M | |
| Total Current Assets | $ 480.5 M | |
| Cash and Short-Term Investments | $ 139.5 M | |
| Cash | $ 139.5 M | |
| Net Receivables | $ 168.4 M | |
| Inventory | $ 153.1 M | |
| Long-Term Investments | $ 3.0 M | |
| LIABILITIES | ||
| Accounts Payable | $ 22.2 M | |
| Short-Term Debt | — | |
| Total Current Liabilities | $ 109.7 M | |
| Net Debt | $ 853.2 M | |
| Total Debt | $ 1.0 B | |
| Total Liabilities | $ 1.6 B | |
| EQUITY | ||
| Total Equity | $ 1.9 B | |
| Retained Earnings | $ 1.6 B | |
| VALUATION & PER-SHARE METRICS | EQUITY & PER-SHARE METRICS | |
| Book Value Per-Share | $ 37.69 | |
| Shares Outstanding | 49.211 M | |
| Revenue Per-Share | $ 5.07 | |
| VALUATION | Market Capitalization | $ 3.6 B |
| Enterprise Value | $ 4.5 B | |
| Enterprise Multiple | 56.829 | |
| Enterprise Multiple QoQ | 4.264 % | |
| Enterprise Multiple YoY | 33.934 % | |
| Enterprise Multiple IPRWA | high: 97.818 median: 89.661 mean: 75.269 PBH: 56.829 low: -18.477 |
|
| EV/R | 18.139 | |
| CAPITAL STRUCTURE | ||
| Asset To Equity | 1.849 | |
| Asset To Liability | 2.177 | |
| Debt To Capital | 0.36 | |
| Debt To Assets | 0.304 | |
| Debt To Assets QoQ | -1.0 % | |
| Debt To Assets YoY | 11195.911 % | |
| Debt To Assets IPRWA | high: 0.857 median: 0.372 mean: 0.315 PBH: 0.304 low: 0.044 |
|
| Debt To Equity | 0.562 | |
| Debt To Equity QoQ | -1.255 % | |
| Debt To Equity YoY | 10523.251 % | |
| Debt To Equity IPRWA | high: 2.449 mean: 1.348 median: 1.198 PBH: 0.562 low: 0.058 |
|
| PRICE-BASED VALUATION | ||
| Price To Book (P/B) | 1.953 | |
| Price To Book QoQ | -11.894 % | |
| Price To Book YoY | -3.644 % | |
| Price To Book IPRWA | high: 8.284 median: 8.284 mean: 7.633 PBH: 1.953 low: -1.407 |
|
| Price To Earnings (P/E) | 83.608 | |
| Price To Earnings QoQ | 34.366 % | |
| Price To Earnings YoY | 9.476 % | |
| Price To Earnings IPRWA | high: 129.484 median: 121.736 PBH: 83.608 mean: 64.18 low: -62.256 |
|
| PE/G Ratio | -2.983 | |
| Price To Sales (P/S) | 14.519 | |
| Price To Sales QoQ | 5.872 % | |
| Price To Sales YoY | 13.879 % | |
| Price To Sales IPRWA | high: 18.101 PBH: 14.519 mean: 10.661 median: 8.942 low: 0.664 |
|
| FORWARD MULTIPLES | ||
| Forward P/E | 70.324 | |
| Forward PE/G | -2.509 | |
| Forward P/S | 46.954 | |
| EFFICIENCY | OPERATIONAL | |
| Operating Leverage | 0.949 | |
| ASSET & SALES | ||
| Asset Turnover Ratio | 0.073 | |
| Asset Turnover Ratio QoQ | -17.106 % | |
| Asset Turnover Ratio YoY | -9.437 % | |
| Asset Turnover Ratio IPRWA | high: 0.739 mean: 0.216 median: 0.172 low: 0.107 PBH: 0.073 |
|
| Receivables Turnover | 1.347 | |
| Receivables Turnover Ratio QoQ | -16.103 % | |
| Receivables Turnover Ratio YoY | -10.054 % | |
| Receivables Turnover Ratio IPRWA | high: 16.87 mean: 3.104 median: 2.054 PBH: 1.347 low: 1.116 |
|
| Inventory Turnover | 0.726 | |
| Inventory Turnover Ratio QoQ | -14.144 % | |
| Inventory Turnover Ratio YoY | -12.863 % | |
| Inventory Turnover Ratio IPRWA | high: 0.884 PBH: 0.726 mean: 0.528 median: 0.474 low: 0.275 |
|
| Days Sales Outstanding (DSO) | 67.734 | |
| CASH CYCLE | ||
| Cash Conversion Cycle Days (CCC) | 161.396 | |
| Cash Conversion Cycle Days QoQ | 8.412 % | |
| Cash Conversion Cycle Days YoY | 16.719 % | |
| Cash Conversion Cycle Days IPRWA | high: 174.711 PBH: 161.396 mean: 130.884 median: 112.282 low: 95.344 |
|
| CAPITAL DEPLOYMENT | ||
| Cash Conversion Ratio | 0.673 | |
| CapEx To Revenue | -0.003 | |
| CapEx To Depreciation | -0.109 | |
| CAPITAL, LIQUIDITY & COVERAGE | CAPITAL STRUCTURE | |
| Total Capital | $ 2.8 B | |
| Net Invested Capital | $ 2.8 B | |
| Invested Capital | $ 2.8 B | |
| Net Tangible Assets | $ -967.66 M | |
| Net Working Capital | $ 370.9 M | |
| LIQUIDITY | ||
| Cash Ratio | 1.272 | |
| Current Ratio | 4.382 | |
| Current Ratio QoQ | 4.204 % | |
| Current Ratio YoY | 35.597 % | |
| Current Ratio IPRWA | high: 6.726 PBH: 4.382 mean: 1.197 low: 0.765 median: 0.765 |
|
| Quick Ratio | 2.985 | |
| Quick Ratio QoQ | 5.882 % | |
| Quick Ratio YoY | 57.206 % | |
| Quick Ratio IPRWA | high: 3.01 PBH: 2.985 mean: 0.87 median: 0.545 low: 0.457 |
|
| COVERAGE & LEVERAGE | ||
| Debt To EBITDA | 13.092 | |
| Cost Of Debt | 0.751 % | |
| Interest Coverage Ratio | 7.055 | |
| Interest Coverage Ratio QoQ | -10.406 % | |
| Interest Coverage Ratio YoY | 29.53 % | |
| Interest Coverage Ratio IPRWA | high: 22.74 PBH: 7.055 mean: -0.454 median: -4.125 low: -41.049 |
|
| Operating Cash Flow Ratio | 0.79 | |
| TIMING / LIQUIDITY | ||
| Days Payables Outstanding (DPO) | 14.834 | |
| DIVIDENDS | ||
| Dividend Coverage Ratio | — | |
| Dividend Payout Ratio | — | |
| Dividend Rate | — | |
| Dividend Yield | — | |
| PERFORMANCE | GROWTH | |
| Asset Growth Rate | 0.864 % | |
| Revenue Growth | -15.847 % | |
| Revenue Growth QoQ | -841.901 % | |
| Revenue Growth YoY | 345.641 % | |
| Revenue Growth IPRWA | high: 30.377 % mean: 6.109 % median: -3.595 % low: -5.691 % PBH: -15.847 % |
|
| Earnings Growth | -28.03 % | |
| Earnings Growth QoQ | -441.954 % | |
| Earnings Growth YoY | 243.379 % | |
| Earnings Growth IPRWA | high: 53.333 % PBH: -28.03 % mean: -58.676 % median: -86.154 % low: -88.947 % |
|
| MARGINS | ||
| Gross Margin | 56.238 % | |
| Gross Margin QoQ | -1.913 % | |
| Gross Margin YoY | 2.885 % | |
| Gross Margin IPRWA | high: 79.923 % median: 72.002 % mean: 71.66 % PBH: 56.238 % low: 40.394 % |
|
| EBIT Margin | 28.846 % | |
| EBIT Margin QoQ | 0.963 % | |
| EBIT Margin YoY | 7.699 % | |
| EBIT Margin IPRWA | PBH: 28.846 % high: 24.503 % mean: -3.267 % median: -5.106 % low: -19.638 % |
|
| Return On Sales (ROS) | 28.756 % | |
| Return On Sales QoQ | 0.648 % | |
| Return On Sales YoY | 7.363 % | |
| Return On Sales IPRWA | PBH: 28.756 % high: 24.503 % median: 4.134 % mean: 3.69 % low: -19.638 % |
|
| CASH FLOW | ||
| Free Cash Flow (FCF) | $ 78.2 M | |
| Free Cash Flow Yield | 2.158 % | |
| Free Cash Flow Yield QoQ | 50.383 % | |
| Free Cash Flow Yield YoY | 37.103 % | |
| Free Cash Flow Yield IPRWA | high: 8.605 % PBH: 2.158 % mean: 1.35 % median: 1.292 % low: -8.277 % |
|
| Free Cash Growth | 33.932 % | |
| Free Cash Growth QoQ | -518.088 % | |
| Free Cash Growth YoY | -313.382 % | |
| Free Cash Growth IPRWA | high: 254.643 % median: 143.21 % mean: 53.055 % PBH: 33.932 % low: -504.42 % |
|
| Free Cash To Net Income | 1.647 | |
| Cash Flow Margin | 34.719 % | |
| Cash Flow To Earnings | 1.825 | |
| VALUE & RETURNS | ||
| Economic Value Added | $ 0.03 | |
| Return On Assets (ROA) | 1.389 % | |
| Return On Assets QoQ | -6.716 % | |
| Return On Assets YoY | -6.212 % | |
| Return On Assets IPRWA | high: 4.793 % PBH: 1.389 % median: -0.589 % mean: -0.958 % low: -8.595 % |
|
| Return On Capital Employed (ROCE) | 2.167 % | |
| Return On Equity (ROE) | 0.026 | |
| Return On Equity QoQ | -6.369 % | |
| Return On Equity YoY | -12.367 % | |
| Return On Equity IPRWA | high: 0.057 PBH: 0.026 median: -0.019 mean: -0.062 low: -0.147 |
|
| DuPont ROE | 2.572 % | |
| Return On Invested Capital (ROIC) | 1.942 % | |
| Return On Invested Capital QoQ | -4.382 % | |
| Return On Invested Capital YoY | -100.819 % | |
| Return On Invested Capital IPRWA | high: 5.652 % PBH: 1.942 % mean: -0.881 % median: -1.726 % low: -2.565 % |
|